Zhang Chaihong, Chen Lihong
Department of Obstetrics and Gynecology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Front Immunol. 2025 Jun 5;16:1586120. doi: 10.3389/fimmu.2025.1586120. eCollection 2025.
BACKGROUND: Tumor cells employ various mechanisms to evade detection and attack by the immune system, a phenomenon known as tumor immune escape, which represents a significant target for immunotherapy. Both primary and secondary immune escape mechanisms pose substantial challenges that hinder the efficacy of immunotherapy. This study aims to systematically examine the knowledge structure, hotspot frontiers, emerging trends, and future directions in the field of tumor immune escape through the application of bibliometric methods and knowledge mapping analysis. METHODS: A comprehensive search of the Web of Science Core Collection (WoSCC) was conducted for publications pertaining to tumor immune escape from January 1, 2015, to November 30, 2024. The annual publication data retrieved from the WoSCC were analyzed utilizing Microsoft Office Excel 2019. Furthermore, bibliometric analysis and visualization were executed using VOSviewer, Biblioshiny, and CiteSpace. RESULTS: This study encompassed a total of 11,128 articles published across 1,612 journals, authored by 71,684 individuals affiliated with 9,254 institutions in 121 countries. The United States, China, and Germany emerged as the leading contributors to this field, collectively accounting for 79.99% of all publications. Notable international collaboration was observed between the United States and China. Frontiers in Immunology, Nature Communications, the Journal for ImmunoTherapy of Cancer, and Nature were identified as the four most influential journals in tumor immune escape research. Zhang Wei was noted for the highest publication output, while Freeman Gordon J achieved the highest citation rate. Fudan University was recognized as the most productive institution, whereas Harvard Medical School was acknowledged as the most cited institution. Current hotspot frontiers in tumor immune escape research include immunotherapy, the tumor microenvironment, PD-L1, and PD-1. Additionally, emerging frontiers in recent years encompass immune checkpoint inhibitors, immune infiltration, natural killer cells, extracellular vesicles, immunogenic cell death, metabolism, ferroptosis, melanoma, lung adenocarcinoma, and prognosis. CONCLUSION: A comprehensive investigation into the mechanisms of tumor immune escape is essential for overcoming the existing challenges in immunotherapy. This study systematically analyzes the current state, research frontiers, and future directions, identifying the most prolific and highly cited documents, journals, authors, institutions, and countries in the field of tumor immune escape.
背景:肿瘤细胞采用多种机制来逃避免疫系统的检测和攻击,这种现象被称为肿瘤免疫逃逸,它是免疫治疗的一个重要靶点。原发性和继发性免疫逃逸机制都带来了巨大挑战,阻碍了免疫治疗的疗效。本研究旨在通过应用文献计量学方法和知识图谱分析,系统地考察肿瘤免疫逃逸领域的知识结构、热点前沿、新兴趋势和未来方向。 方法:对科学网核心合集(WoSCC)进行全面检索,查找2015年1月1日至2024年11月30日期间与肿瘤免疫逃逸相关的出版物。利用Microsoft Office Excel 2019对从WoSCC检索到的年度出版数据进行分析。此外,使用VOSviewer、Biblioshiny和CiteSpace进行文献计量分析和可视化。 结果:本研究共纳入11128篇发表在1612种期刊上的文章,作者来自121个国家的9254个机构,共71684人。美国、中国和德国是该领域的主要贡献者,合计占所有出版物的79.99%。观察到美国和中国之间有显著的国际合作。《免疫学前沿》《自然通讯》《癌症免疫治疗杂志》和《自然》被确定为肿瘤免疫逃逸研究中最具影响力的四种期刊。张伟的发文量最高,而弗里曼·戈登·J的被引率最高。复旦大学被认为是发文量最多的机构,而哈佛医学院被认为是被引次数最多的机构。肿瘤免疫逃逸研究当前的热点前沿包括免疫治疗、肿瘤微环境、程序性死亡配体1(PD-L1)和程序性死亡受体1(PD-1)。此外,近年来的新兴前沿包括免疫检查点抑制剂、免疫浸润、自然杀伤细胞、细胞外囊泡、免疫原性细胞死亡、代谢、铁死亡、黑色素瘤、肺腺癌和预后。 结论:全面研究肿瘤免疫逃逸机制对于克服免疫治疗中现存的挑战至关重要。本研究系统地分析了当前状况、研究前沿和未来方向,确定了肿瘤免疫逃逸领域中发文最多和被引次数最多的文献、期刊、作者、机构和国家。
Medicine (Baltimore). 2025-6-20
Clin Cosmet Investig Dermatol. 2025-6-19
Front Neurol. 2025-6-5
Cancer Cell. 2025-2-10
Semin Cancer Biol. 2025-5
Cancer Immunol Immunother. 2024-11-2